These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31987791)

  • 1. Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians.
    Toh JJH; Chuah SY; Jhingan A; Chong WS; Thng STG
    J Am Acad Dermatol; 2020 Jun; 82(6):1517-1519. PubMed ID: 31987791
    [No Abstract]   [Full Text] [Related]  

  • 2. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
    Grimes PE; Hamzavi I; Lebwohl M; Ortonne JP; Lim HW
    JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications and limitations of afamelanotide for treating vitiligo.
    Passeron T
    JAMA Dermatol; 2015 Mar; 151(3):349-50. PubMed ID: 25607635
    [No Abstract]   [Full Text] [Related]  

  • 5. Indications and limitations of afamelanotide for treating vitiligo-reply.
    Lim HW; Grimes PE; Lebwohl M
    JAMA Dermatol; 2015 Mar; 151(3):350. PubMed ID: 25607828
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
    Korobko IV; Lomonosov KM
    Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic treatment of vitiligo : Balance and current developments].
    Meurer M; Ceric-Dehdari P
    Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo: an update on systemic treatments.
    Searle T; Al-Niaimi F; Ali FR
    Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phototherapy for vitiligo, what's new?
    Paro Vidolin A; Aurizi C; Leone G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and Maintenance Treatments for Vitiligo.
    Passeron T
    Dermatol Clin; 2017 Apr; 35(2):163-170. PubMed ID: 28317526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the use of fractional CO
    Bakr RM; Abdel-Gaber RM; Tawfik YM
    Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo.
    Gamil H; Attwa E; Ghonemy S
    Clin Exp Dermatol; 2010 Dec; 35(8):919-21. PubMed ID: 20456387
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet-rich plasma: Potential role in combined therapy for vitiligo.
    Shih S
    Dermatol Ther; 2019 Jan; 32(1):e12773. PubMed ID: 30338878
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
    Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
    Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 19. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
    Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
    Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.